Company profile INMB

INmune Bio Inc
inmune bio inc. is a clinical stage immuno-oncology company focused on harnessing the patient’s immune system to treat cancer. inkmune, the company’s lead product, primes patient’s nk cells (natural killer cells) to kill cancer. inmune is targeting residual disease, the cancer cells that survive initial treatments that return to cause the cancer relapse. by controlling re...sidual disease, patients may live longer. using a novel mechanism of action and a precision medicine approach, inkmune therapy should enhance nk cells’ ability to eliminate residual disease. Show More
Quarter analysis & expected interestLast update: February 09 2024 17:11:31.

After 39 days of this quarter the interest is at 33.0. Based on that we can calculate that during remaining 52 days it will total up to 77.0.
INmune Bio expected interest is significantly higher compared to previous quarter (+51.0%) and same quarter last year (+156.7%).

YearQ1Q2Q3Q4
2019116
140
20.7% QoQ
121
-13.6% QoQ
105
-13.2% QoQ
2020 48
-58.6% YoY -54.3% QoQ
65
-53.6% YoY 35.4% QoQ
272
124.8% YoY 318.5% QoQ
106
1.0% YoY -61.0% QoQ
2021 150
212.5% YoY 41.5% QoQ
106
63.1% YoY -29.3% QoQ
174
-36.0% YoY 64.2% QoQ
184
73.6% YoY 5.7% QoQ
2022 93
-38.0% YoY -49.5% QoQ
61
-42.5% YoY -34.4% QoQ
42
-75.9% YoY -31.1% QoQ
48
-73.9% YoY 14.3% QoQ
2023 30
-67.7% YoY -37.5% QoQ
0
-100.0% YoY -100.0% QoQ
39
-7.1% YoY inf% QoQ
51
6.2% YoY 30.8% QoQ
2024 33
10.0% YoY -35.3% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and INmune Bio search interestLast update: February 09 2024 17:11:30.
Correlation coefficient between keyword and revenue is 0.11
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 17:11:32.

The average 5 years interest of INmune Bio was 7.6 per week.
The last year interest of INmune Bio compared to the last 5 years has changed by -61.32%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -70.21%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 17:11:39.

After 39 days of this quarter the interest is at 73.0. Based on that we can calculate that during remaining 52 days it will total up to 170.0.
INmune Bio stock expected interest is significantly higher compared to previous quarter (+inf%) and same quarter last year (+844.4%).

YearQ1Q2Q3Q4
201930
121
303.3% QoQ
19
-84.3% QoQ
211
1010.5% QoQ
2020 33
10.0% YoY -84.4% QoQ
51
-57.9% YoY 54.5% QoQ
188
889.5% YoY 268.6% QoQ
99
-53.1% YoY -47.3% QoQ
2021 208
530.3% YoY 110.1% QoQ
245
380.4% YoY 17.8% QoQ
174
-7.4% YoY -29.0% QoQ
155
56.6% YoY -10.9% QoQ
2022 42
-79.8% YoY -72.9% QoQ
186
-24.1% YoY 342.9% QoQ
73
-58.0% YoY -60.8% QoQ
73
-52.9% YoY 0.0% QoQ
2023 18
-57.1% YoY -75.3% QoQ
61
-67.2% YoY 238.9% QoQ
83
13.7% YoY 36.1% QoQ
0
-100.0% YoY -100.0% QoQ
2024 73
305.6% YoY inf% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and INmune Bio stock search interestLast update: February 09 2024 17:11:38.
Correlation coefficient between keyword and revenue is -0.41
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 17:11:40.

The average 5 years interest of INmune Bio stock was 8.21 per week.
The last year interest of INmune Bio stock compared to the last 5 years has changed by -49.21%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -47.61%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 17:11:46.

After 39 days of this quarter the interest is at 58.0. Based on that we can calculate that during remaining 52 days it will total up to 135.0.
INMB stock price expected interest is significantly higher compared to previous quarter (+221.4%) and same quarter last year (+285.7%).

YearQ1Q2Q3Q4
201923
168
630.4% QoQ
183
8.9% QoQ
100
-45.4% QoQ
2020 117
408.7% YoY 17.0% QoQ
101
-39.9% YoY -13.7% QoQ
238
30.1% YoY 135.6% QoQ
20
-80.0% YoY -91.6% QoQ
2021 288
146.2% YoY 1340.0% QoQ
101
0.0% YoY -64.9% QoQ
398
67.2% YoY 294.1% QoQ
231
1055.0% YoY -42.0% QoQ
2022 31
-89.2% YoY -86.6% QoQ
72
-28.7% YoY 132.3% QoQ
51
-87.2% YoY -29.2% QoQ
114
-50.6% YoY 123.5% QoQ
2023 35
12.9% YoY -69.3% QoQ
163
126.4% YoY 365.7% QoQ
70
37.3% YoY -57.1% QoQ
42
-63.2% YoY -40.0% QoQ
2024 58
65.7% YoY 38.1% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and INMB stock price search interestLast update: February 09 2024 17:11:45.
Correlation coefficient between keyword and revenue is -0.36
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 17:11:48.

The average 5 years interest of INMB stock price was 9.98 per week.
The last year interest of INMB stock price compared to the last 5 years has changed by -35.87%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -36.82%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for INmune Bio clinical trials to provide analysis

Correlation between past revenue and INmune Bio clinical trials search interest

There is not enough data for INmune Bio clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for INmune Bio clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for INmune Bio cancer treatment to provide analysis

Correlation between past revenue and INmune Bio cancer treatment search interest

There is not enough data for INmune Bio cancer treatment to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for INmune Bio cancer treatment to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 17:12:04.

After 39 days of this quarter the interest is at 100.0. Based on that we can calculate that during remaining 52 days it will total up to 233.0.
INMB news expected interest is significantly higher compared to previous quarter (+606.1%) and same quarter last year (+468.3%).

YearQ1Q2Q3Q4
201956
53
-5.4% QoQ
46
-13.2% QoQ
53
15.2% QoQ
2020 17
-69.6% YoY -67.9% QoQ
76
43.4% YoY 347.1% QoQ
37
-19.6% YoY -51.3% QoQ
89
67.9% YoY 140.5% QoQ
2021 0
-100.0% YoY -100.0% QoQ
128
68.4% YoY inf% QoQ
92
148.6% YoY -28.1% QoQ
36
-59.6% YoY -60.9% QoQ
2022 212
inf% YoY 488.9% QoQ
35
-72.7% YoY -83.5% QoQ
72
-21.7% YoY 105.7% QoQ
31
-13.9% YoY -56.9% QoQ
2023 41
-80.7% YoY 32.3% QoQ
118
237.1% YoY 187.8% QoQ
0
-100.0% YoY -100.0% QoQ
33
6.5% YoY inf% QoQ
2024 100
143.9% YoY 203.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and INMB news search interestLast update: February 09 2024 17:12:03.
Correlation coefficient between keyword and revenue is 0.44
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 17:12:06.

The average 5 years interest of INMB news was 5.08 per week.
The last year interest of INMB news compared to the last 5 years has changed by 10.63%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 40.5%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for INmune Bio Alzheimer's disease treatment to provide analysis

Correlation between past revenue and INmune Bio Alzheimer's disease treatment search interest

There is not enough data for INmune Bio Alzheimer's disease treatment to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for INmune Bio Alzheimer's disease treatment to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for INmune Bio neurodegenerative diseases to provide analysis

Correlation between past revenue and INmune Bio neurodegenerative diseases search interest

There is not enough data for INmune Bio neurodegenerative diseases to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for INmune Bio neurodegenerative diseases to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for INMB company profile to provide analysis

Correlation between past revenue and INMB company profile search interest

There is not enough data for INMB company profile to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for INMB company profile to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for INMB
Earnings date: 2024-02-29 After close
Company name: INmune Bio Inc
Sector: Professional, Scientific, and Technical Services
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-14T12:00:00Z

GlobeNewswire
INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer's Disease

2026-05-13T12:00:00Z

GlobeNewswire
INmune Bio Named Founding Member of the American Biotech Innovation Alliance (ABIA) as U.S. Biotech Sector Navigates Strategic Inflection Point

2026-05-07T20:00:00Z

GlobeNewswire
INmune Bio Inc. Announces First Quarter 2026 Results and Provides Business Update

2026-05-05T20:00:00Z

GlobeNewswire
INmune Bio and Anthony Nolan Announce Strategic Expansion of CORDStrom™ MSC Platform Collaboration to Target RDEB, Oncology, and Inflammatory Diseases

2026-05-05T11:00:00Z

BusinessWire
Biotech Leaders Launch National Alliance to Define the Future of American Innovation

2026-04-30T12:00:00Z

GlobeNewswire
INmune Bio Inc. to Report First Quarter 2026 Financial Results and Provide Corporate Update on Thursday, May 7th

2026-04-16T12:00:00Z

GlobeNewswire
INmune Bio Inc. Announces New Preclinical Data at AACR 2026 Demonstrating INB03 (XPro1595) Overcomes Resistance and Reduces Metastases in HER2-Positive Breast Cancer Models

2026-03-30T20:00:00Z

GlobeNewswire
INmune Bio Inc. Announces 2025 Results and Provides Business Update

2026-03-24T12:00:00Z

GlobeNewswire
INmune Bio Inc. to Report Year End 2025 Financial Results and Provide Corporate Update on Monday, March 30th.

2026-03-11T12:01:00Z

Analyst Upgrades
LUCID CAPITAL MARKETS Upgrades INmune Bio to Buy, Raises Price Target to $9

2026-02-23T14:25:00Z

GlobeNewswire
INmune Bio to Detail XPro1595 Registrational Strategy in Upcoming Alzheimer's Webinar

2026-02-19T17:15:00Z

GlobeNewswire
INmune Bio Announces Upcoming Webinar to Present New Clinical Data on CORDStrom™ for RDEB

2026-02-12T12:00:00Z

GlobeNewswire
INmune Bio Announces FDA Alignment on Integrated Phase 2b/3 Registration Pathway for XPro1595 in Early Alzheimer's Disease

2026-02-10T13:00:00Z

GlobeNewswire
INmune Bio Advances CORDStrom™ Towards UK Marketing Authorization in RDEB

2026-01-27T14:25:00Z

GlobeNewswire
INmune Bio Inc Issues Shareholder Letter Reviewing 2025 Milestones and Outlining 2026 Strategic Initiatives